1 Product identity
Ingredient risk
1 ingredient to use with caution
Magnesium Potassium Aspartate
BrandCountry Life Target-Mins→Mineral Tablet or Pill 9 ingredients 1 caution DSLD #333315Net contents: 180 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2025-04-24
2 Ingredients (9)
IngredientGroupSafety
CelluloseCellulose—
Stearic AcidStearic Acid—
HypromelloseHypromellose—
GlycerinGlycerol—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Potassium — Conditionally Safe
⚠ Hyperkalemia risk
⚠ Dangerous with ACE inhibitors
Silicon — Generally Safe
⚠ Very low toxicity
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID333315
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2025-04-24
6 More from Country Life Target-Mins
Calcium 1,000 mg Magnesium 500 mg Zinc 25 mg with Vitamin DMagnesium Potassium Aspartate7 Cite this page
Vancouver
Pkhakadze G. Magnesium Potassium Aspartate — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 01]. Available from: https://supplement.ge/products/magnesium-potassium-aspartate-333315/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG